Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Infections × Cefazolin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Wound Infection 1 Surgical Wound Infection 1 Prostatic Neoplasms 1 Laryngeal Neoplasms 1 Infections 1

Interventions

Voriconazole 2 Ribavirin 2 Levofloxacin 2 Fluconazole 2 Ciprofloxacin 2 telaprevir 1 peginterferon alfa-2a 1 liposomal amphotericin B 1 lime 1 human papillomavirus vaccine, L1 type 16, 18 1 amphotericin B, deoxycholate drug combination 1 Vancomycin 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Trimethoprim 1 Therapeutics 1 Tazobactam 1 Surgical Procedures, Operative 1 Sulfamethoxazole 1 Piperacillin, Tazobactam Drug Combination 1 Piperacillin 1 Palivizumab 1 Olive Oil 1 Ofloxacin 1 Nystatin 1 Moxifloxacin 1 Itraconazole 1 Diet 1 Cefepime 1 Cefazolin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00867295 2010-06-02

TIVAD

Istanbul University

Phase 3 Completed

Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡